Thomas G. Frinzi - 03 Jan 2023 Form 4 Insider Report for STAAR SURGICAL CO (STAA)

Role
President & CEO, Director
Signature
/s/ Samuel J. Gesten as attorney-in-fact for Thomas G. Frinzi
Issuer symbol
STAA
Transactions as of
03 Jan 2023
Net transactions value
$0
Form type
4
Filing time
04 Jan 2023, 15:06:33 UTC
Previous filing
17 Jun 2022
Next filing
16 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction STAA Common Shares Options Exercise $0 +87,805 +1857% $0.000000 92,534 03 Jan 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction STAA Common Stock Options Options Exercise $0 +160,638 $0.000000 160,638 03 Jan 2023 Common Stock 160,638 $51.25 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Award of 87,805 Restricted Stock Units of Common Stock (RSU), subject to forfeiture rights, which lapse as to 29,268 of the RSUs on 1/3/24, 29,268 of the RSUs on 1/3/25, and 29,269 of the RSUs on 1/3/26.
F2 The options granted become exercisable as follows: 1/3 on 1/3/2024 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 1/3/2026.